Harfst & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Extended Market ETF
VXF
|
+$1.39M |
| 2 |
ResMed
RMD
|
+$463K |
| 3 |
Invesco QQQ Trust
QQQ
|
+$454K |
| 4 |
UnitedHealth
UNH
|
+$298K |
| 5 |
Autodesk
ADSK
|
+$215K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$6.65M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
+$2.46M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.83M |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$1.68M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$783K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.54% |
| 2 | Technology | 3.72% |
| 3 | Consumer Staples | 3.7% |
| 4 | Industrials | 2.9% |
| 5 | Healthcare | 1.43% |
Similar funds
Harfst & Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Harfst & Associates held 86 positions worth $237M, down 3.4% from $245M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Harfst & Associates withdrew a net $11.2M in Q2 2018, closing 5 positions and reducing 14 holdings. Its most notable exit was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $1.83M position sold in full.
By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 48% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Harfst & Associates opened a new position in ResMed worth $474K.
- Harfst & Associates's largest Q2 2018 buy was ResMed: 4,577 shares worth $474K.
- Harfst & Associates added most to Vanguard Extended Market ETF in Q2 2018, an estimated $1.39M increase.
- Harfst & Associates's biggest Q2 2018 reduction was Invesco S&P 500 Low Volatility ETF, cutting an estimated $6.65M.
- Harfst & Associates fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2018, selling an estimated $1.83M.
- Harfst & Associates's ten largest holdings make up 86% of its $237M portfolio in Q2 2018.
- Harfst & Associates opened 6 new positions and closed 5 in Q2 2018.
- Harfst & Associates's portfolio value fell 3.4% quarter-over-quarter to $237M.
Based on Harfst & Associates's 13F filing for Q2 2018, filed 10 Aug 2018.